Evidence map›Paper›PMID 30344543›Full record

ArticleJournal of geriatric cardiology : JGC2018

Nicorandil pretreatment inhibits myocardial apoptosis and improves cardiac function after coronary microembolization in rats.

Wen-Kai He, Qiang Su, Jiao-Bao Liang, Xian-Tao Wang, Yu-Han Sun, Lang Li

Abstract read
In one paragraph

Article in Journal of geriatric cardiology : JGC, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Puerarin pretreatment attenuates cardiomyocyte apoptosis induced by coronary microembolization in rats by activating the PI3K/Akt/GSK-3β signaling pathway.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2021
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Wen-Kai HeDepartment of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Qiang SuDepartment of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Jiao-Bao LiangDepartment of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xian-Tao WangDepartment of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Yu-Han SunDepartment of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Lang LiDepartment of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
First Affiliated Hospital of GuangXi Medical University · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNicorandil (NIC) is a vasodilatory drug used to treat angina. However, its efficacy of cardioprotection in coronary microembolization (CME) is largely unknown. This study was undertaken to determine whether nicorandil pretreatment could attenuate myocardial apoptosis and improve cardiac function after CME in rats.

methodsForty-five rats were randomly divided into a Sham group, a CME group and a CME + NIC (NIC) group (

resultsCompared to that in the Sham group, cardiac function in the CME group was significantly decreased (

conclusionsNIC pretreatment inhibited CME-induced myocardial apoptosis and improved cardiac function through blockade of the mitochondrial and death receptor-mediated apoptotic pathways.

Indexed as

ApoptosisCardiac functionCoronary microembolizationNicorandil

Identifiers

PMID30344543
PMCPMC6188981
OpenAlexW2912154118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.